Aktie ELN ELANIX BIOTECHNOLOGIES AG
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Elanix Biotechnologies AG Xetra

Aktien

ELN

DE000A0WMJQ4

ELN

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
ELANIX BIOTECHNOLOGIES AG: RÜCKTRITT UND NOMINIERUNG IM AUFSICHTSRAT
Elanix Biotechnologies AG Announces Executive Changes
Elanix Biotechnologies Ag Reports Earnings Results for the Half Year Ended June 30, 2019
Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES
Anja Silling acquired 12.85% stake in Elanix Biotechnologies AG (DB:ELN) from Lee-Ann Laurent-Applegate for €1 million.
18-04-2019Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Elanix Biotechnologies Ag Announces Nomination of the Chairman of the Supervisory Board, the Vice Chairman and Members of the Board
Elanix Biotechnologies AG Announces Resignation of Jürgen Kullmann from the Supervisory Board
Elanix Biotechnologies AG Announces Change in Supervisory Board
Elanix Plans To Sell Shares Of Company
Elanix Biotechnologies AG (DB:ELN) cancelled the acquisition of Inno 4 Cell AG.
Elanix Biotechnologies AG announced that it has received €0.870298 million in funding
Elanix Biotechnologies AG Appoints Egon Minar to the Joint Role of Chief Operating Officer and Chief Financial Officer
Elanix Biotechnologies AG announced that it expects to receive €0.870298 million in funding
Elanix Biotechnologies AG signs an Agreement with MedBioSante
Elanix Biotechnologies AG announced that it expects to receive €2.5 million in funding from Yorkville Advisors Global LP
Elanix Biotechnologies AG announced that it expects to receive €11 million in funding
Elanix Biotechnologies AG announced that it has received €1.125071 million in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0WMJQ Aktie
  4. ELN Aktie
  5. Nachrichten Elanix Biotechnologies AG
  6. Andere Sprachen